1620 Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.7K Sell
411
-600
-59% -$52.5K 0.02% 350
2026
Q1
$86.2K Hold
1,011
0.06% 256
2025
Q4
$79.9K Hold
1,011
0.05% 256
2025
Q3
$80.8K Hold
1,011
0.05% 255
2025
Q2
$91.9K Hold
1,011
0.07% 241
2025
Q1
$94.7K Sell
1,011
-80
-7% -$7.16K 0.07% 226
2024
Q4
$99.2K Buy
1,091
+312
+40% +$29.8K 0.08% 220
2024
Q3
$80.9K Sell
779
-645
-45% -$65.7K 0.06% 251
2024
Q2
$138K Buy
+1,424
New +$131K 0.11% 188

Other funds holding CL

1620 Investment Advisors's CL Position: Q2 2026 in Review

1620 Investment Advisors reduced its Colgate-Palmolive (CL) stake by 59% in Q2 2026, selling an estimated $52.5K and leaving 411 shares worth $37.7K. The position accounts for 0.02% of the portfolio, ranked #350.

1620 Investment Advisors first reported a position in CL in Q2 2024 and has held it in 9 quarters since. The position peaked at $138K in Q2 2024. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • 1620 Investment Advisors held 411 shares of Colgate-Palmolive worth $37.7K as of Q2 2026.
  • 1620 Investment Advisors sold 600 Colgate-Palmolive shares in Q2 2026, an estimated $52.5K.
  • Colgate-Palmolive made up 0.02% of 1620 Investment Advisors's portfolio in Q2 2026, its #350 holding.
  • 1620 Investment Advisors first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 9 quarters since.
  • 1620 Investment Advisors's Colgate-Palmolive position peaked at $138K in Q2 2024.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.